Reasons for satisfaction with the use of the 52-mg levonorgestrel intrauterine system.
Brazil
levonorgestrel intrauterine system
long-acting reversible contraceptives
reasons for choice
satisfaction
Journal
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
ISSN: 1879-3479
Titre abrégé: Int J Gynaecol Obstet
Pays: United States
ID NLM: 0210174
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
revised:
24
02
2022
received:
22
12
2021
accepted:
04
04
2022
pubmed:
10
4
2022
medline:
12
10
2022
entrez:
9
4
2022
Statut:
ppublish
Résumé
To assess the reasons to use, reasons they liked, satisfaction with, and possibilities of recommendation to other women of the levonorgestrel 52-mg intrauterine system (LNG-IUS) by users. A cross-sectional study was conducted at the University of Campinas, Campinas, Brazil from January to July 2021. We enrolled users who came to the clinic, and we applied a pre-tested structured questionnaire with open-ended questions. We performed descriptive analyses of the variables, assessing the level of satisfaction with, and the reasons regarding the possibility of continuing to use, the IUS. Of the 517 enrolled women, 251 (48%) were aged 35 years or older (mean age 33.9 ± 9.0 years), 276 (53%) were white, 14 (3%) were adolescents, 155 (30%) were nulligravidas, and 307 (59.4%) reported experiencing amenorrhea in the last 90 days. Common reasons why women liked to use the LNG-IUS included both the reduction of menstrual bleeding (419 women; 81%) and dysmenorrhea (290 women; 56.1%). Nine out of 10 users (517 women; 91%) were satisfied with the method, and the majority would recommend it to other women. We found a high satisfaction rate among LNG-IUS users mainly due to the reduction of both menstrual bleeding and dysmenorrhea.
Substances chimiques
Contraceptive Agents, Female
0
Levonorgestrel
5W7SIA7YZW
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
577-582Subventions
Organisme : UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research
Organisme : Organization of the American States (OAS)
Organisme : Brazilian National Research Council (CNPq)
ID : 573747/2008-3
Organisme : Fundação de Apoio à Pesquisa do Estado de São Paulo (FAPESP)
ID : 2015/20504-9
Informations de copyright
© 2022 International Federation of Gynecology and Obstetrics.
Références
Gormley R, Vickers B, Cheng B, Norman WV. Comparing options for females seeking permanent contraception in high resource countries: a systematic review. Reprod Health. 2021;18:154.
Fraser IS. Non-contraceptive health benefits of intrauterine hormonal systems. Contraception. 2010;82:396-403.
Kaunitz AM, Bissonnette F, Monteiro I, Lukkari-Lax E, Muysers C, Jensen JT. Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol. 2010;116:625-632.
Soini T, Hurskainen R, Grénman S, Mäenpää J, Paavonen J, Pukkala E. Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube. Acta Oncol. 2016;55:1281-1284.
Carvalho N, Margatho D, Cursino K, Benetti-Pinto CL, Bahamondes L. Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial. Fertil Steril. 2018;110:1129-1136.
World Health Organization model list of essential medicines-22nd list, 2021. World Health Organization; 2021 (WHO/MHP/HPS/EML/2021.02) Licence: CC BY-NC-SA 3.0 IGO.
Black K, Lotke P, Buhling KJ, Zite NB. A review of barriers and myths preventing the more widespread use of intrauterine contraception in nulliparous women. Eur J Contracept Reprod Health Care. 2012;17:340-350.
Coles CB, Shubkin CD. Effective, recommended, underutilized: a review of the literature on barriers to adolescent usage of long-acting reversible contraceptive methods. Curr Opin Pediatr. 2018;30:683-688.
Payne JB, Sundstrom B, DeMaria AL. A qualitative study of young women's beliefs about intrauterine devices: fear of infertility. J Midwifery Womens Health. 2016;61:482-488.
Svahn S, Hultstrand JN, Tydén T, Ragnar ME. Contraception use and attitudes: women's concerns regarding hormonal contraception and copper intrauterine devices. Eur J Contracept Reprod Health Care. 2021;26:473-478.
Backman T, Huhtala S, Luoto R, Tuominen J, Rauramo I, Koskenvuo M. Advance information improves user satisfaction with the levonorgestrel intrauterine system. Obstet Gynecol. 2002;99:608-613.
Peipert JF, Zhao Q, Allsworth JE, et al. continuation and satisfaction of reversible contraception. Obstet Gynecol. 2011;117:1105-1113.
Hameed W, Ishaque M, Gul X, et al. Does courtesy bias affect how clients report on objective and subjective measures of family planning service quality? A comparison between facility- and home-based interviews. Open Access J Contracept. 2017;9:33-43.
Luukkainen T, Lahteemmaki P, Toivonen J. Levonorgestrel releasing intrauterine device. Ann Med. 1990;22:85-90.
Jamieson S. Likert scales: how to (ab) use them. Med Educ. 2004;38:1217-1218.
The SAS System for Windows (Statistical Analysis System), version 9.2. SAS Institute Inc, 2002-2008.
Abma JC, Martinez GM. Sexual activity and contraceptive use among teenagers in the United States, 2011-2015. Natl Health Stat Report. 2017;104:1-23.
Pritt NM, Norris AH, Berlan ED. Barriers and facilitators to adolescents' use of long-acting reversible contraceptives. J Pediatr Adolesc Gynecol. 2017;30:18-22.
Mestad R, Secura G, Allsworth JE, Madden T, Zhao Q, Peipert JF. Acceptance of long-acting reversible contraceptive methods by adolescent participants in the contraceptive CHOICE project. Contraception. 2011;84:493-498.
Kagesten A, Bajos N, Bohet A, Moreau C. Male experiences of unintended pregnancy: characteristics and prevalence. Hum Reprod. 2015;30:186-196.
Nanda G, Rademacher KH, Solomon M, Mercer S, Wawire J, Ngahu R. Experiences with the levonorgestrel intrauterine system (LNG-IUS) in Kenya: qualitative interviews with Mirena users and their partners. Eur J Contracept Reprod Health Care. 2018;23:303-308.
Meaidi A, Skalls K, Gerds A, Lidegaard O, Torp PC. Decline in Danish use of oral tranexamic acid with increasing use of the levonorgestrel-releasing intrauterine system: a nation wide drug utilization study. Contraception. 2020;101:321-326.
Hubacher D, Masaba R. Carolyne Kemunto Manduku, Mario Chen, Valentine Veena The levonorgestrel intrauterine system:cohort study to assess satisfaction in a postpartum population in Kenya. Contraception. 2015;91:295-300.
Snow R, Hardy E, Kneuper E, Hebling EM, Hall G. Women's responses to menses and nonbleeding intervals in the USA. Brazil and Germany Contraception. 2007;76:23-29.
Kaur R, Kaur K, Kaur R. Menstrual hygiene, management, and waste disposal: practices and challenges faced by girls/women of developing countries. J Environ Public Health. 2018;2018:1730964.